Miglustat in Cystic Fibrosis

NCT00742092 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: miglustat
DRUG: placebo

Sponsor

Actelion